IR
Superintel
OverviewMarketsWatchlist
© 2026 IR SuperintelMethodologyContact

Aisling Capital Management LP

Q3 2022 Holdings

Filed 2022-11-03 | 17 holdings | $78.2M | 13F-HR | View on SEC ↗ · Holdings Table ↗

Sign in to see sub-manager breakdown

IssuerClassCUSIPValue ↓Shares% Portfolio
BridgeBio Pharma Inc. (Bbio)(BBIO)COM10806X102$60.3M6,068,12577.1%
Aclaris Theraputics Inc. (Acrs)(ACRS)COM00461U105$10.0M634,45512.8%
Biomea Fusion Inc. (Bmea)(BMEA)COM09077A106$7.8M798,75710.0%
Syndax Pharmaceuticals, Inc. (Sndx)(SNDX)COM87164F105$24.6K1,025,0000.0%
Verona Pharma plc (Vrna)(VRNA)SPONSORED ADS925050106$13.6K1,332,4850.0%
Monte Rosa Therapeutics Inc. (Glue)(GLUE)COM61225M102$12.0K1,472,3310.0%
Nuvation Bio Inc. (Nuvb)(NUVB)COM CL A67080N101$5.7K2,541,0090.0%
Poseida Therapeutics Inc. (Pstx)(PSTXUSD)COM73730P108$3.7K1,043,2670.0%
Elevation Oncology Inc. (Elev)COM28623U101$3.2K2,834,9100.0%
Reneo Pharmaceuticals Inc. (Rphm)(RPHM)COM75974E103$3.0K886,0750.0%
Spruce Biosciences, Inc. (Sprb)COM85209E109$1.7K1,205,5110.0%
Viracta Therapeutics Inc. (Virx)COM92765F108$1.2K288,5710.0%
Marker Therapeutics, Inc. (Mrkr)COM57055L107$1.2K3,142,8570.0%
Aeglea Biotherapeutics Inc. (Agle)(AGLEUSD)COM00773J103$8901,691,1510.0%
Avrobio, Inc. (Avro)COM05455M100$6461,009,7790.0%
Atreca Inc. (Bcel)(BCELUSD)CL A COM04965G109$609387,6530.0%
Talaris Therapeutics Inc. (Tals)COM87410C104$460175,0000.0%